GL
TMO icon

Graypoint LLC’s Thermo Fisher Scientific TMO Stock Holding History

Graypoint LLC’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$899K Sell
2,217
-488
-18% -$204K 0.05% 231
2025
Q1 		$1.35M Buy
2,705
+250
+10% +$135K 0.08% 162
2024
Q4 		$1.28M Sell
2,455
-537
-18% -$295K 0.08% 161
2024
Q3 		$1.85M Buy
2,992
+41
+1% +$24.3K 0.12% 129
2024
Q2 		$1.63M Sell
2,951
-39
-1% -$22.3K 0.11% 133
2024
Q1 		$1.74M Buy
2,990
+1,241
+71% +$696K 0.13% 128
2023
Q4 		$928K Sell
1,749
-60
-3% -$29K 0.07% 175
2023
Q3 		$916K Buy
1,809
+230
+15% +$123K 0.09% 159
2023
Q2 		$824K Sell
1,579
-495
-24% -$267K 0.08% 151
2023
Q1 		$1.2M Buy
2,074
+715
+53% +$403K 0.13% 115
2022
Q4 		$748K Buy
1,359
+321
+31% +$170K 0.09% 151
2022
Q3 		$527K Buy
1,038
+339
+48% +$190K 0.07% 182
2022
Q2 		$380K Buy
699
+194
+38% +$107K 0.05% 214
2022
Q1 		$298K Buy
505
+37
+8% +$21.3K 0.03% 266
2021
Q4 		$312K Buy
+468
New +$292K 0.03% 247

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Graypoint LLC's TMO Position: Q2 2025 in Review

Graypoint LLC reduced its Thermo Fisher Scientific (TMO) stake by 18% in Q2 2025, selling an estimated $204K and leaving 2,217 shares worth $899K. The position accounts for 0.05% of the portfolio, ranked #231.

Graypoint LLC first reported a position in TMO in Q4 2021 and has held it in 15 quarters since. The position peaked at $1.85M in Q3 2024. 2,453 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

  • Graypoint LLC held 2,217 shares of Thermo Fisher Scientific worth $899K as of Q2 2025.
  • Graypoint LLC sold 488 Thermo Fisher Scientific shares in Q2 2025, an estimated $204K.
  • Thermo Fisher Scientific made up 0.05% of Graypoint LLC's portfolio in Q2 2025, its #231 holding.
  • Graypoint LLC first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 15 quarters since.
  • Graypoint LLC's Thermo Fisher Scientific position peaked at $1.85M in Q3 2024.
  • 2,453 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on Graypoint LLC's 13F filing for Q2 2025, filed 15 Jul 2025.